Are affordable pharmaceuticals within reach for developing countries - Clarifying the access situation of today and projecting beyond the Paragraph 6-Agreement
The increasing spread of global pandemics such as HIV/AIDS, tuberculosis (TB) and malaria, in particular in developing countries, has forced the engagement of industrialized countries and pharmaceutical companies. Because medicines to cure these diseases are often under patent protection, they are not affordable for people in developing countries where health crises prevail. In November 2001, WTO